- Company Directors - L
- Laforce James
Insider Trading History of Laforce James
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Laforce James since 2005.
The trader's CIK number is 1075514.
At the time of the last reporting, Laforce James was the Director of Arena Pharmaceuticals Inc. (stock ticker symbol ARNA).
Also see all insider trading activities at Arena Pharmaceuticals Inc.
Note that in the past
LAFORCE JAMES also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Blackrock World Investment Trust (BWC) by Laforce James
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | BWC | 250 | $3,675 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Blackrock Health Sciences Trust (BME) by Laforce James
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | BME | 150 | $3,753 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Arena Pharmaceuticals Inc (ARNA) by Laforce James
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | ARNA | 3,500 | $9,590 | 0 | $0 | 0 | $0 |
| 2008 | ARNA | 10,000 | $51,800 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Blackrock Enhanced Global Dividend Trust (BOE) by Laforce James
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | BOE | 200 | $5,002 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Blackrock Enhanced Equity Dividend Trust (BDJ) by Laforce James
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | BDJ | 600 | $7,818 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Blackrock High Income Shares (HIS) by Laforce James
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | HIS | 200 | $566 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Laforce James:
1. Blackrock World Investment Trust (BWC)
2. Blackrock Health Sciences Trust (BME)
3. Arena Pharmaceuticals Inc (ARNA)
4. Blackrock Enhanced Global Dividend Trust (BOE)
5. Blackrock Enhanced Equity Dividend Trust (BDJ)
6. Blackrock High Income Shares (HIS)
Table 1. Insider trading of Blackrock World Investment Trust (BWC) by Laforce James
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-12-09 | BWC | Buy | 250 | 14.70 | 3,675 |
Table 2. Insider trading of Blackrock Health Sciences Trust (BME) by Laforce James
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-04-22 | BME | Buy | 150 | 25.02 | 3,753 |
Table 3. Insider trading of Arena Pharmaceuticals Inc (ARNA) by Laforce James
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-05-14 | ARNA | Buy | 3,500 | 2.74 | 9,590 |
| 2008-05-13 | ARNA | Buy | 10,000 | 5.18 | 51,800 |
Table 4. Insider trading of Blackrock Enhanced Global Dividend Trust (BOE) by Laforce James
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-06-23 | BOE | Buy | 200 | 25.01 | 5,002 |
Table 5. Insider trading of Blackrock Enhanced Equity Dividend Trust (BDJ) by Laforce James
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-12-09 | BDJ | Buy | 600 | 13.03 | 7,818 |
Table 6. Insider trading of Blackrock High Income Shares (HIS) by Laforce James
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-06-23 | HIS | Buy | 200 | 2.83 | 566 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Laforce James
(Director of Arena Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.